11/19
08:30 am
flgt
Oncology Specimen Provider Reference Medicine Announces Launch of Characterized Specimens, Enabling Increased Speed and Efficiency for Assay Developers
Low
Report
Oncology Specimen Provider Reference Medicine Announces Launch of Characterized Specimens, Enabling Increased Speed and Efficiency for Assay Developers
11/19
03:02 am
flgt
Fulgent Genetics, Inc. (NASDAQ: FLGT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Fulgent Genetics, Inc. (NASDAQ: FLGT) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
11/11
11:15 pm
flgt
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
11:15 pm
flgt
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Fulgent Genetics, Inc. (NASDAQ: FLGT) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/11
08:09 am
flgt
Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $26.00 to $22.00. They now have a "neutral" rating on the stock.
Low
Report
Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $26.00 to $22.00. They now have a "neutral" rating on the stock.
11/10
08:29 am
flgt
Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth [Yahoo! Finance]
Medium
Report
Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth [Yahoo! Finance]
11/10
08:18 am
flgt
Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
Medium
Report
Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations [Yahoo! Finance]
11/9
02:14 am
flgt
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline [Yahoo! Finance]
Medium
Report
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline [Yahoo! Finance]
11/8
07:00 am
flgt
Fulgent Reports Third Quarter 2024 Financial Results
High
Report
Fulgent Reports Third Quarter 2024 Financial Results
11/5
08:00 am
flgt
Fulgent to Participate in Upcoming Conferences
Medium
Report
Fulgent to Participate in Upcoming Conferences
10/31
08:00 am
flgt
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans¹
Medium
Report
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans¹
10/17
04:05 pm
flgt
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
Low
Report
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
9/18
09:24 am
flgt
Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107% [Yahoo! Finance]
Low
Report
Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107% [Yahoo! Finance]